Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: muddphudd who wrote (1034)	11/17/1998 9:10:00 PM
From: HoyaBob	Read Replies (1) \| Respond to of 1580

MERCK split: Well, at some point it becomes nearly impossible for small investors (whatever that is) to buy more than small lots of 10 -50 shares. Unless they want to be a Berkshire Hathaway, I suspect that they have some ideal cap at which they will find things too rich for access. Recent breakout made me add a few hundred shares w. covered calls at 155. Even last year, the three-digit barrier seemed to be out of range for most drug stocks. Now, its commonplace, given the tremendous run-up in prices. BTW, I loved WLA's 3-1 split earlier this year. I want to have "thousands" of shares of MRK, someday. I know split is like having four quarters for a buck, but lower price helps increase ownership distribution (my unsubstantiated opinion) and decrease the options premiums.